Is Microdosing Safer, Cheaper, or Riskier
Were getting a lot of questions [from CPG clients], with interest peaking after the comments from Walmart, so we started to look at some of the studies that we were conducting to see if we could add some questions for people taking these GLP-1 drugs. As for Hartmans clients, she says, food and beverage companies have already been steadily cutting sugar from beverages, and reducing sugar, saturated fat, and sodium from many of their foods, so in many respects, GLP-1 drugs may just accelerate this trend
doi: 10.1038/nature05414
WeightWatchers The GLP-1 programme offers several types of support
Giese finds that patients who drop 30 pounds or more with semaglutide usually want to stay on a small maintenance dose
A 2022 meta-analysis of 37 RCTs involving 3,048 patients, published in Frontiers in Pharmacology , found that berberine significantly reduced fasting plasma glucose by an average of 0.82 mmol/L and HbA1c by 0.63% without significantly increasing hypoglycemia risk
